SPDR® S&P® U.S. Health Care Select Sector UCITS ETF | SXLVRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 9.5 | 26.7 | 10.0 | -4.1 | 7.8 | |
+/-Cat | -8.0 | 17.3 | 14.7 | -0.9 | 4.0 | |
+/-B’mrk | - | 8.5 | 4.2 | -1.5 | 0.4 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
Closing Price 22/11/2024 | USD 43.79 | |
Day Change | 0.83% | |
Morningstar Category™ | Sector Equity Healthcare | |
Volume | 287483 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BWBXM617 | |
Fund Size (Mil) 22/11/2024 | USD 398.18 | |
Share Class Size (Mil) 22/11/2024 | USD 398.18 | |
Ongoing Charge 31/05/2024 | 0.15% |
Investment Objective: SPDR® S&P® U.S. Health Care Select Sector UCITS ETF | SXLV |
The investment objective of the Fund is to track the performance of large sized U. S. health care companies in the S&P 500 Index. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
- - | ||
Inception Date 07/07/2015 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
S&P Health Care Slct Dly Cap25/20 NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for SPDR® S&P® U.S. Health Care Select Sector UCITS ETF | SXLV | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Eli Lilly and Co | Healthcare | 12.13 |
UnitedHealth Group Inc | Healthcare | 9.66 |
Johnson & Johnson | Healthcare | 7.13 |
AbbVie Inc | Healthcare | 6.68 |
Merck & Co Inc | Healthcare | 4.81 |
Increase Decrease New since last portfolio | ||
SPDR® S&P® U.S. Health Care Select Sector UCITS ETF | SXLV |